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ABSTRACT 
Background: Scores on cognitive screening tools for dementia are associated with 
premorbid IQ. It has been suggested that screening scores should be adjusted 
accordingly. However, no study has examined whether premorbid IQ variation affects 
screening accuracy.  
Objective:  To investigate whether the screening accuracy of a widely used cognitive 
screening tool for dementia, the Addenbrooke’s cognitive examination-III (ACE-III), 
is improved by adjusting for premorbid IQ. 
Methods: 171 UK based adults (96 memory service attendees diagnosed with 
dementia and 75  healthy volunteers over the age of 65 without subjective memory 
impairments) completed the ACE-III and the Test of Premorbid Function (TOPF). 
The difference in screening performance between the ACE-III alone and the ACE-III 
adjusted for TOPF was assessed against a reference standard; the presence or absence 
of a diagnosis of dementia (Alzheimer’s disease, vascular dementia or others). 
Results: Logistic regression and receiver operating curve analyses indicated that the 
ACE-III has excellent screening accuracy (93% sensitivity, 94% specificity) in 
distinguishing those with and without a dementia diagnosis. Although ACE-III scores 
were associated with TOPF scores, TOPF scores may be affected by having dementia 
and screening accuracy was not improved by accounting for premorbid IQ, age or 
years of education.  
Conclusion: ACE-III screening accuracy is high and screening performance is robust 
to variation in premorbid IQ, age and years of education. Adjustment of ACE-III cut-
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offs for premorbid IQ is not recommended in clinical practice. The analytic strategy 
used here may be useful to assess the impact of premorbid IQ on other screening 
tools.  
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INTRODUCTION 
Individuals screened for dementia vary widely in premorbid IQ, with implications for 
the interpretation of performance on cognitive screening tests[1]. Premorbid IQ in 
dementia is hard to measure as it requires a test that is both highly associated with 
current IQ in individuals without dementia and robust to the effects of dementia[2]. 
Reading of irregular English words meets the first criterion[3] and despite some  
controversy over whether it meets the second[4, 5]  it is the most established 
methodology for premorbid IQ measurement[2]. There are a number of English 
irregular word reading tests, of which the Test of Premorbid Function (TOPF)[6] is 
the most recent. The TOPF is perhaps the gold standard as it was developed and co-
normed with the most widely used measure of IQ, the Wechsler Adult Intelligence 
Scale IV[7]  
 
The association of estimated Premorbid IQ based on irregular word reading with one 
widely used and recommended[8] screening tool, the Addenbrooke’s Cognitive 
Examination III (ACE-III)[9] is unknown. Premorbid IQ is, however, strongly 
associated with other screening tools such as the Mini Mental State Examination 
(MMSE)[1, 10]  and Montreal Cognitive Assessment (MocA) [11, 12]. As a 
consequence, it has been suggested that scores on cognitive screening tests should be 
adjusted to account for premorbid IQ[11]. Despite this, the critical issue of whether 
adjustment increases the accuracy of screening tools  and thus the clinical utility of 
such adjustment is unknown. 
 
Consequently, the current study has three novel aims. The first aim is to evaluate the 
association of ACE-III with TOPF performance in individuals without dementia and 
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thus the potential influence of premorbid IQ on ACE-III performance. Given the 
controversy over the impact of dementia on premorbid IQ, the second aim is to 
evaluate the impact of dementia on TOPF performance and thus the utility of the 
TOPF as a measure of premorbid IQ in dementia.  The third and primary aim is to 
evaluate whether adjusting ACE-III scores for TOPF premorbid IQ improves 
screening accuracy and is thus clinically useful.   
 
MATERIALS AND METHODS 
Design 
 The study assessed screening tests (index tests) against a criterion (reference 
standard).  Consequently it is written up according to Standards for Reporting of 
Diagnostic Accuracy (STARD)[13] and Standards for Reporting of Diagnostic 
Accuracy in Dementia[14] guidelines.  
 
Participants 
Eligibility criteria 
All participants were fluent in English and had capacity to consent. Exclusion criteria 
included a current diagnosis of a DSM-IV depressive disorder, anxiety disorder, 
bipolar disorder, substance related disorder, schizophrenia or other psychotic disorder, 
diagnosed intellectual disability and significant uncorrected sensory deficits. As this 
study was the first from a dataset which will also be used to examine the relationship 
of neuropsychological functioning to Cognitive Behavioural Therapy (CBT), 
participants reporting current or previous experience of CBT were excluded.  
 
Recruitment procedures  
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Data on ACE-III and TOPF were prospectively collected. The dementia group 
constituted a consecutive referrals sample of 102 people with mild dementia (last 
MMSE score > 24 or equivalent on other cognitive screen[15]). Dementia was 
diagnosed according to consensus criteria[16-19] by a psychiatrist led, multi-
disciplinary memory clinic. All clients had cognitive assessment, with extent of 
assessment driven by client need as per British Psychological Society guidelines[20]. 
Results of cognitive screening tests (ACE-III, Addenbrooke’s Cognitive Examination 
Revised (ACE-R) [21], MMSE, MoCA) from an initial diagnostic interview were 
discussed in the multidisciplinary team with interpretation guided by experienced 
clinical psychologists specialising in neuropsychology. Where diagnosis was unclear, 
a more extensive neuropsychological assessment was conducted by a clinical 
psychologist. In determining client functioning, client and informant report were used. 
Where informant report was unavailable and functional status was unclear, 
occupational therapy assessment was used to clarify. Diagnostic subtypes included 
Alzheimer’s disease[17], vascular dementia[19], mixed dementia[17], dementia in 
Parkinson’s disease[16] and Frontotemporal dementia[18]. When criteria were not 
met, a diagnosis of dementia not otherwise specified was made according to ICD-10 
criteria[22]. Intermediate diagnoses such as possible Alzheimer’s disease were not 
included. The control group constituted a convenience sample of 75 healthy 
volunteers over the age of 65 without a diagnosis of dementia (determined through 
self-report) and not reporting subjective memory problems. They were recruited by 
advertisement in community groups and from the Join Dementia Research 
database[23].  All participants from both dementia and control groups gave informed 
consent to participate in the study. Work was conducted in compliance with ethical 
guidelines on human experimentation[24] Ethical approval was given by NRES 
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Committee London – City Road & Hampstead (REC Reference 14/LO/0554). Sample 
size estimation for the main logistic regression analysis[25, 26], suggested a minimum 
of 100 participants in total was required. Data were collected between July 2014 and 
July 2016. 
 
Test methods 
Demographic information was obtained verbally from all participants and for the 
dementia group was verified via electronic healthcare records. The presentation order 
of the TOPF and the ACE-III was randomised across participants to minimise order 
effects. Measures were administered in clinics or participants’ homes by five 
psychology graduates trained in administration and scoring of the TOPF and ACE-III 
and supervised by a clinical psychologist with a postgraduate diploma in clinical 
neuropsychology.  
 
Test materials 
Index tests 
We compared two index tests in terms of screening performance; the ACE-III alone 
and the ACE-III adjusted for TOPF scores. The index tests were not incorporated 
within the reference standard so as to avoid diagnostic circularity.  
Reference standard  
Performance on index tests was evaluated against a reference standard of whether the 
participant belonged to the dementia group or the control group as defined above. 
Reference standard assessors were blind to index test results but not vice versa. 
 
ACE-III 
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The ACE-III is a validated ‘pen and paper’ cognitive screening tool for dementia[9] 
covering five cognitive domains including memory, language, orientation and 
attention, verbal fluency and visuospatial abilities, with a maximum score of 100. The 
recommended cut-off score for screening cognitive impairments related to dementia 
is 87/88[9]. Given mixed findings with optimal cut-off varying from 76/77[27]  to  
87/88[9] our cut-off score was exploratory and devised using receiver operating 
characteristic (ROC) analysis to to calculate an optimal cut-off score for which the 
Youden’s index (sensitivity+specificity-1) was maximized [28] 
 
ACE-III adjusted for TOPF 
The TOPF[6] involves reading up to 70 irregular English words. The raw score (total 
number correct) can be converted into two estimates of premorbid IQ. The unadjusted 
premorbid IQ is based on published tables developed through regression with TOPF 
alone as a predictor of IQ. The adjusted premorbid IQ is obtained through entering 
TOPF score along with age, gender and years of education into a regression equation. 
In support of construct validity, both unadjusted and adjusted TOPF premorbid IQ 
show strong associations with current measures of IQ, are reliable over time and 
robust to effects of brain injury[6].   
 
In order to derive a single index test which optimally combined both the TOPF and 
ACE-III scores, we used the TOPF and ACE-III as predictors in a logistic regression 
model[29]. The performance of this model in correctly identifying those with 
dementia was compared against the ACE-III alone using recommended 
methodologies[29] as described below. As this index was novel, cut-offs were not 
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pre-defined, but based on the value of scores derived from the logistic regression that 
maximised the Youden index in a ROC analysis[30].  
 
Statistical methods: 
Data were analysed using R[31] and the pROC[32], BinomTools[33], 
QuantPsych[34] and BaylorEdPsych[35] packages. In examining between group 
demographic differences, all continuous variables were assessed for parametric 
assumptions. Where these were met, t-tests were conducted, where not; Mann 
Whitney U tests were used. For categorical variables Chi Squared or Fisher’s exact 
test were used, depending on minimum cell counts[36] Where necessary to quantify 
uncertainty, 95% confidence intervals were calculated. 
 
For aims one and two regarding the association of ACE-III with TOPF and the impact 
of having a dementia diagnosis on TOPF performance, we used hierarchical multiple 
linear regression to statistically control for potential confounding variables of age, 
gender and years of education, all of which can influence TOPF performance[6]. 
These potential confounders were entered in a first block with variables of interest 
added in a second block. For all regression models, outliers with undue influence on 
coefficients were investigated, and where necessary, removed. Where assumptions of 
regression[36] were not met, bootstrapped bias-corrected accelerated confidence 
intervals were generated to increase model robustness[36]. 
 
To assess the primary aim, we compared the prediction of dementia status using two 
binomial logistic regression models; one model with ACE-III alone as a predictor and 
the other with TOPF and ACE-III as predictors. We assessed performance of 
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individual predictors using beta coefficients, Wald statistics and odds ratios. We 
assessed overall model effect size using Nagelkerke’s R2 and compared overall model 
performance using the Bayesian information criterion (BIC)[29]. To provide 
screening accuracy statistics for both models and thus an indication of clinical utility, 
we used the predicted probability of dementia from each model in ROC analyses to 
derive optimal cut-offs with corresponding numbers of true and false negatives and 
positives. We also obtained sensitivity, specificity and Area Under The Curve (AUC) 
values. The unadjusted TOPF premorbid IQ was used in all analyses due to 
multicollinearity[36] in regression equations containing the adjusted TOPF score. 
However, we re-ran the main analysis again with the adjusted TOPF score to ensure 
this did not alter results. Some participants were administered ACE-III (n=41) and 
others, the ACE-R (n=9) in determining their original diagnoses. This may have 
artificially inflated ACE-III sensitivity and specificity and could have an impact on 
our main results regarding TOPF utility in diagnosis. To assess this, we re-ran our 
main analyses twice, first excluding participants where ACE-III was used in diagnosis 
and second excluding participants where ACE-R or ACE-III were used in diagnosis. 
 
RESULTS:   
Participant flow 
345 people were initially approached to take part in the study. Of 285 potentially 
eligible, 179 participants took part. In the control and dementia sample those 
potentially eligible did not differ from participants in gender (Χ2 = 0.006 and 0.002 
respectively, p>0.05) or age (t= 0.77, and -0.06 respectively p>0.05). Those in the 
dementia sample did not differ in diagnostic subtype (whether they had Alzheimer’s 
disease or another dementia type) either (Χ2 =0.2, p>0.05). Figure 1 shows a modified 
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STARD[13] flow diagram detailing flow of participants through the study and reasons 
for exclusion. Eight participants had missing data on one or more measures. Data 
were missing completely at random (Little’s MCAR test p<0.05) and < 5%, so was 
removed listwise as recommended by Graham [37]. Thus, the final analysis included 
171 participants (96 with dementia and 75 controls).  
 
-Insert figure 1 about here –  
 
Demographic and clinical characteristics   
Table 1 shows summary statistics for demographics as well as ACE-III (which in the 
dementia group indicates level of impairment) and TOPF scores for both groups. The 
dementia group were significantly older, had significantly fewer years’ education and 
lower ACE-III and TOPF scores than the control group. Gender and ethnicity did not 
significantly differ between groups.   
 
- Insert table 1 about here -  
 
Analyses for aims 1 and 2  
All analyses were hierarchical multiple linear regressions. Standardised betas (β) with 
bootstrap bias corrected accelerated 95% confidence intervals (CI)s for all significant 
predictors (at p<0.05) after adjustment for all other predictors are reported for 
variables of interest and potential confounders (age, gender and years of education). 
 
1. Association between TOPF and ACE-III scores in those without dementia 
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Our results suggest that ACE-III scores are highly and independently associated of 
with premorbid IQ scores: In controls, higher TOPF premorbid IQ scores 
independently predicted higher ACE-III scores (β=0.65, CI 0.38 to 0.81). This was 
the case even when controlling for gender, age and education, with older age (β = -
0.24, CI -0.48 to -0.05) the only other significant independent predictor of higher 
ACE-III.   
 
2a) Impact of dementia on TOPF performance 
Our results suggest that TOPF performance is associated with and may be affected by 
dementia: In an analysis conducted on the whole sample, having a dementia diagnosis 
was a significant independent predictor of poorer TOPF performance (β=-0.45, CI -
0.56 to -0.33). This was the case even when controlling for the significant prediction 
of TOPF performance by years of education (β=0.38, CI 0.25 to 0.48) and age 
(β=0.17, CI 0.06 to 0.29).   
 
2b) Degree of cognitive impairment and TOPF performance 
Our results indicate that TOPF performance may be lower in those with increased 
cognitive impairment (as measured by ACE-III scores) independent of any 
differences in age and education and consequently suggest that TOPF may be more 
affected with greater cognitive impairment : The impact of degree of cognitive 
impairment (ACE-III score) and dementia subtype on TOPF performance was 
assessed in the dementia sample. Lower ACE-III score was predictive of lower TOPF 
score (β=0.49, CI 0.31 -0.66) even when controlling for the fact that lower age 
(β=0.19, CI 0.04 -0.33) and fewer years of education (β=0.34, CI 0.18 -0.48) were 
  
13 
also significant predictors of lower TOPF scores. Type of dementia (Alzheimer’s 
Disease vs. any other dementia subtype) was not associated with TOPF performance.  
 
Analyses for primary aim: Does adjusting ACE-III scores by TOPF scores 
improve screening accuracy? 
Preliminary analyses 
No adverse events were reported in using index or reference standard tests. There 
were no indeterminate results on index testing. The index test was performed after the 
reference standard and median (IQR) time difference was 145 (323.5) days. 
 
Logistic regression analysis 
Our results suggest that ACE-III screening accuracy is robust to variance in 
premorbid IQ, age and years of education: In the binomial logistic regression model 
with ACE-III score alone as a predictor of dementia status, and the model with ACE-
III and TOPF scores as predictors, lower ACE-III score was the only significant 
(p<0.05) predictor of increased odds of dementia (see table two for regression 
coefficients).  
 
As age and education relate to premorbid IQ[6] and differed between the dementia 
and control groups we ran two further binomial logistic regression models, one with 
ACE-III, age and years of education as predictors and one with the TOPF in addition 
to these predictors. Across both models, ACE-III was the only significant predictor 
(see Table 2 for regression coefficients). The significance of ACE-III across models 
and the lack of significance of other predictors implies that if individuals have the 
same ACE-III score but differ in TOPF score, age, gender, or years of education, 
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there is no change in the odds of them having dementia. The increase in BIC and 
similarity of R2 across models suggests that the predictive power of a model 
containing the ACE-III alone is not enhanced by the other variables included here (see 
Table 2 for model R2 (effect size) and BIC values).  
 
- Insert table 2 about here -  
 
Screening accuracy metrics for all models 
Numbers correctly and incorrectly classified by each model are given in Table 3 
ROC analyses indicated that the optimal ACE-III cut-off was 88.5 with an associated 
sensitivity of 93% and specificity of 94%. Discrimination metrics (sensitivity, 
specificity, area under the curve) from this and ROC analyses based on the predicted 
probabilities from all logistic regression models are given in Table 2. There was no 
difference between model AUCs (p>0.05), further supporting our conclusion that 
ACE-III is robust to variance in premorbid IQ and demographics.  
 
- Insert table 3 about here -  
 
Use of the recommended ACE-III cut-off and adjusted TOPF premorbid IQ 
Our results suggest that using the recommended ACE-III cut-offs and the adjusted 
TOPF premorbid IQ index does not alter our findings: The optimal ACE-III cut-off in 
our sample was 88.5. We assessed whether using the previously recommended cut-off 
of 87/88[9] would change results, which it did not; results given in Tables 2 and 3 
show overlap of confidence intervals with all other models. Similarly, re-running the 
TOPF and ACE-III model with the adjusted rather than unadjusted TOPF premorbid 
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IQ score as a predictor did not change results. ACE-III remained the only significant 
predictor (β=0.34, Z=-5.80, p<0.001, OR=0.71; Model R2=0.81, BIC=92.42, 
AUC=0.97) and AUC test against other models was non-significant (p>0.05).  
 
Analysis excluding those who had ACE-III or ACE-R as part of their diagnosis.  
The main analysis was rerun twice, once excluding those who were administered 
ACE-III as part of their initial diagnostic process (dementia n = 61) and again 
excluding those administered the ACE-III or ACE R in diagnosis (dementia n =52). 
This produced very similar results to our original findings. The main finding of 
robustness of the ACE-III to variation in premorbid IQ, education, or age was 
replicated in both analyses and ACE-III was once again the only significant predictor 
of dementia status in both analyses with very similar odds ratios to the original 
analysis (odds ratios of 0.74, 95% CI 0.66-0.81 and 0.75, 95% CI 0.67 – 0.82 
respectively).  In terms of diagnostic accuracy metrics, sensitivity of diagnosis using 
ACE-III in the analyses was 93.1%, (95% CI, 82.75-98.28) and 92% (95% CI, 81.63-
97.96) respectively and specificity was 93.33%, (95% CI 86.66-98.67) and 93.33% 
(95% CI, 85.33-98.67) respectively. These point values for sensitivity and specificity 
were around 0.5%-1.5% lower than in the original analyses. However, the overlap of 
95% confidence intervals with original point values suggest no significant difference 
between these and original findings and as stated above the main finding of lack of 
TOPF utility in adding to screening accuracy was unchanged.  
 
DISCUSSION 
This study is the first to evaluate whether adjusting a dementia-screening tool for 
premorbid IQ improves screening accuracy. We found that a recommended and 
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widely used screening tool (ACE-III) had excellent screening accuracy and was 
robust to variation in premorbid IQ (as measured by TOPF), age, and years of 
education. Our results do not support the proposed clinical practice[11] of adjusting 
screening cut-offs for these factors. 
 
A subsidiary aim of our study was to examine the association of ACE-III with 
premorbid IQ. It has been argued that screening cut-off scores should be adjusted as a 
corollary of a strong association between premorbid IQ and screening[11]. Our study 
mitigates against this given that we found such an association but no increase in 
screening accuracy.  One reason for this apparent contradiction may have been the 
excellent screening performance of the ACE-III alone, which left little room for 
improvement.  
 
A second subsidiary aim was to preliminarily evaluate the impact of dementia on a 
gold standard measure of premorbid IQ (TOPF) through comparison to controls. 
Although our design does not allow inference of causality, our results indicate that 
possibly TOPF scores may be affected by dementia. Thus one reason for lack of 
impact on screening accuracy could be that the TOPF is a poorer measure of 
premorbid IQ than other irregular word reading tests [2].We think this is unlikely as 
the TOPF is highly associated with the most widely used current IQ test[6] and there 
is evidence that any effect of dementia on the TOPF is much less than the effect of 
dementia on tests of current cognitive function[6]. In support of this, the TOPF in our 
sample appeared less associated with the ACE-III in those with dementia than those 
without.  Furthermore, making TOPF more robust to dementia impact by using a 
derived premorbid IQ score adjusted for demographics did not change our results. 
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Additionally, our findings are similar to those for other premorbid IQ measures in 
indicating that impact of dementia may be mitigated by less severe cognitive 
impairment[5] albeit within the limited range afforded by our mild dementia sample. 
This is important as it is in mild cases and in the clarification of potential false 
negatives that premorbid IQ measurement is particularly clinically useful[2]. Finally, 
the lower TOPF in the dementia sample may reflect a difference in underlying IQ 
between those with and without mild dementia as suggested by the cognitive reserve 
hypothesis[38]. Consequently, while our results potentially indicate that dementia 
may have some effect on TOPF scores, they do not do so conclusively and this is 
unlikely to fully account for our main results, which would likely be similar for other 
measures of premorbid IQ.  
 
Generalisability of our results to clinical practice is enhanced by the fact that, unlike 
many studies, having a carer was not an inclusion criterion. Our dementia sample was 
also very similar to UK estimated prevalence in diagnostic subtype breakdown[39]. 
Additionally, our control participants and those with dementia were similar in gender 
and age to eligible non-participants. Participants with dementia were also similar in 
diagnostic breakdown to eligible non-participants, suggesting no selection bias on 
these domains.   
 
The robustness of our conclusions is increased by the fact that changing ACE-III cut-
offs did not affect results. Thus while the optimal ACE-III cut-off in our sample was 
88.5, we would suggest continued clinical use of the proposed cut-off of 87/88[9]. A 
further strength of the study was that we used recommended methods, for comparing 
the incremental value of adding new markers to a diagnostic model[30] 
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Limitations worth noting include the fact that the control sample was younger and 
more educated than the dementia sample. Although we controlled for this statistically 
and our main finding was unchanged when age and years of education were added to 
regression models, it should be addressed by sample matching in future.  Severity of 
dementia may also have been inaccurately measured in our sample, where a third 
have a non-Alzheimer’s dementia, as the ACE-R has not been validated for people 
with non-Alzheimer’s dementias and early cognitive symptoms of such dementias 
may not be accurately assessed by the MMSE.  Additionally,  we did not record 
interventions occurring between reference standard and index assessment, which 
could have reduced dementia severity[14] and thus made dementia more difficult to 
detect. We did not record alternative diagnoses in either group, which may also have 
affected index test performance[14], potentially also making dementia more difficult 
to detect. Importantly, absence of dementia diagnosis in the control group was self-
reported and not confirmed by cognitive tests, with consequent potential undiagnosed 
dementia in this group. This could inaccurately inflate the false positive rate of index 
tests. However, all of these issues should make screening performance worse and the 
high accuracy of ACE-III found in our study  may indicate that they did not affect our 
results. Finally,  index assessment was done some time after the reference standard 
and there could have been deterioration in participants’ cognitive function[14], 
making it more severe and dementia easier to detect.  This, as well as the fact that 
assessors were not blind to dementia status of the participants [40] perhaps accounts 
for the fact that our screening accuracy values for ACE-III were slightly higher than 
have been found before[9, 27].  Screening accuracy may also have been slightly 
inflated by the use, in some cases, of the ACE-III or ACE-R in the diagnostic process.  
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In summary, we found that screening accuracy of ACE-III was robust to variation in 
premorbid IQ and demographic variables and our study supports use of the 
recommended 87/88 cut-off[9]. The TOPF may not be sufficiently robust to dementia 
but this seems unlikely to fully account for our results and may not be different to 
other premorbid IQ measures. Importantly, association of screening tools with 
premorbid IQ is not sufficient to recommend adjusting screening cut-offs, at least in a 
high IQ sample using the ACE-III. To increase generalisability of findings, future 
research should assess the impact of premorbid IQ on screening accuracy of other 
tools (e.g. MMSE) in those with lower intellectual capacity with the analytic strategy 
used here.  
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Figure 1 -
1Modified STARD flowchart showing flow of participants through the study   
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Table 1: Demographic variables and TOPF and ACE-III scores for dementia and 
control groups (Median ± IQR)  
Variable 
 
Control (n= 
75) 
Dementia (n= 96)  
 
U/Fisher’s 
Exact test 
Age 72±8 81±10 1552*** 
Sex (M:F) 28:47 43:53 N/S 
Ethnicity 
(White:Non-White) 
1:74 8:88 N/S 
Education (years) 16±6  12±5  2059.5*** 
Dementia type 
 
- 
60 AD:8 VaD:15 Mixed 
VaD and AD:13 Other 
- 
ACE-III 96± 6 74±16 232.5*** 
TOPF 119±8 104.5±22  1462*** 
Due to non-normal distributions, medians and Interquartile Ranges (IQRs) are 
reported rather than means and standard deviations. 
***, Significant at P<0.001 using Mann-Whitney U test. 
N/S, Non-significant using Χ2 or Fisher’s exact test.  
AD, Alzheimer’s Disease; VaD, Vascular Dementia; ‘Other’ dementia type 
included two with Dementia in Parkinson’s disease, one with Frontotemporal 
Dementia and 10 with Unspecified Dementia. 
 
  
  
27 
Table 2 Logistic regression coefficients and diagnostic accuracy metrics for prediction of dementia by 
all diagnostic indexes 
 Logistic regression coefficients Diagnostic accuracy metrics 
Diagnostic 
index 
Significant 
predictors in 
model (β, Wald 
Statistic, OR) 
Model 
R2 
Model 
BIC 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
AUC 
(95% CI) 
ACE-III alone 
(88.5 Cut-off) 
ACE-III (β=-0.33, 
Z=-6.14***, OR= 
0.72) 
0.81 87.3 93.74% (86.45 
to 97.92) 
94.66% (88 to 
98.67) 
0.967 
(0.94 to 
0.99) 
ACE-III and 
TOPF 
ACE-III (β=-0.35 
Z= -5.84***, 
OR=0.71) 
0.81 92.11 92.7% (86.45 
to 97.91) 
96% (89.33 to 
1) 
0.97 (0.94 
to 0.99) 
ACE-III and 
demographics 
ACE-III (β=-0.3 
Z=-5.66***, 
OR=0.74) 
0.82 92.82 94.79 (86.45 to 
98.95) 
94.67 (86.67 to 
1)  
0.97 (0.95 
to 1) 
ACE-III, TOPF, 
demographics 
ACE-III (β=-0.3 
Z= -5.1*** 
OR=0.74) 
0.82 97.95 94.79% (85.41 
to 98.96) 
93.33% (86.67 
to 98.67) 
0.97(0.95 
to 0.99) 
ACE-III alone 
(87/88 cut-off) 
- - - 94.79% (89.58 
to 98.96) 
92% (85.33 to 
97.33) 
- 
*** P<0.001 
R2, Nagelkerke’s R2 (an index of model effect size, with larger values indicating higher predictive 
power); BIC, Model Bayesian information Criterion (lower values indicate that the model accounts 
better for the data); CI, bootstrapped, bias corrected accelerated confidence interval; AUC, area under 
the ROC curve; β, β coefficient associated with a predictor in the logistic regression model; Z, value of 
the Wald Statistic for a predictor in the logistic regression model; OR, Odds Ratio; Demographics 
included gender, age and years of education.  
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Table 3 Cross-tabulation of dementia status of participants with results of each diagnostic index  
 Diagnostic indices 
 ACE-III alone 
(cut-off 88/89) 
ACE-III and 
TOPF 
ACE-III and 
demographics 
ACE-III, 
TOPF, 
demographics 
ACE-III 
alone (cut-
off 87/88) 
 +Ve -Ve +Ve -Ve +Ve -Ve +Ve -Ve +Ve -Ve 
Dementia n 90* 6 § 89* 7§ 91* 5§ 91* 5§ 91* 5§ 
No dementia n 4‡ 71¶ 3‡ 72¶ 4‡ 71¶ 5‡ 70¶ 6‡ 69¶ 
Demographics, included gender, age and years of education; +ve, dementia is present according to an 
index; -ve, dementia is absent according to an index. 
*True positives on index compared to the reference standard. 
‡False positives on index compared to the reference standard. 
¶True negatives on index compared to the reference standard. 
§False negatives on index compared to the reference standard. 
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